As part of the TRACEPIGEN project, Dr Ivana Boljević spent two weeks in July on a short-stay secondment at UCL Cancer Institute, Department of Cancer Biology, Medical Genomics group (London, UK). She was hosted by Prof Stephan Beck and Dr Nnenna Kannu. During this period, she gained insights into the ongoing projects at the UCL,
Lung cancer in Serbia Scientists at IORS, supported by the Science Fund of the Republic of Serbia, in collaboration with the Institute for Pulmonary Diseases of Vojvodina and the Pulmonary Diseases Clinic, University Clinical Center Nis have provided an up-to-date overview of the current epidemiological situation concerning lung cancer in Serbia published by Cavic et al.
Scientists at IORS, supported by the Science Fund of the Republic of Serbia, in collaboration with Beck lab at UCL Cancer Institute have performed a systematic benchmarking of sequencing-based methods for measuring DNA methylation and developed a framework for data integration across different platforms in a paper published by Tanić et al. in Nature Biotechnology. Epigenetics
Training school for circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) was held on March 28-30, 2022, at Aarhus University Hospital in Denmark. It was co-organized by TRANSCOLONCAN COST Action together with DCCC Danish Research Center for ctDNA, TRACEPIGEN (Science Fund of the Republic of Serbia), and the European Liquid Biopsies Academy- ELBA. TRACEPIGEN
Training the new generation of scientists in the hot topic of liquid biopsy biomarkers. TRACEPIGEN project will co-organize the Training school for circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) in collaboration with COST Action TRANSCOLONCAN, the European Liquid Biopsy Academy, and the Danish National Research Center for ctDNA. The workshop will take place
